BioMerieux SA (BMXMF)
101.91
0.00 (0.00%)
USD |
OTCM |
May 17, 16:00
BioMerieux 1 Year Total Returns (Daily): -1.12% for May 17, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| May 17, 2024 | -1.12% |
| May 16, 2024 | -1.12% |
| May 15, 2024 | 3.28% |
| May 14, 2024 | 3.28% |
| May 13, 2024 | 3.28% |
| May 10, 2024 | 0.38% |
| May 09, 2024 | 0.38% |
| May 08, 2024 | 0.38% |
| May 07, 2024 | 1.79% |
| May 06, 2024 | 1.79% |
| May 03, 2024 | 1.79% |
| May 02, 2024 | -1.13% |
| May 01, 2024 | -1.13% |
| April 30, 2024 | 2.52% |
| April 29, 2024 | 2.52% |
| April 26, 2024 | 1.85% |
| April 25, 2024 | -2.16% |
| April 24, 2024 | -2.16% |
| April 23, 2024 | -0.10% |
| April 22, 2024 | -0.75% |
| April 19, 2024 | 1.44% |
| April 18, 2024 | -0.33% |
| April 17, 2024 | 3.23% |
| April 16, 2024 | 3.23% |
| April 15, 2024 | 3.79% |
| Date | Value |
|---|---|
| April 12, 2024 | 6.30% |
| April 11, 2024 | 7.99% |
| April 10, 2024 | 8.72% |
| April 09, 2024 | 11.28% |
| April 08, 2024 | -0.69% |
| April 05, 2024 | -0.69% |
| April 04, 2024 | 2.35% |
| April 03, 2024 | 4.81% |
| April 02, 2024 | 2.85% |
| April 01, 2024 | 2.85% |
| March 28, 2024 | 2.85% |
| March 27, 2024 | 2.85% |
| March 26, 2024 | 3.61% |
| March 25, 2024 | 3.61% |
| March 22, 2024 | 4.07% |
| March 21, 2024 | 4.07% |
| March 20, 2024 | 4.94% |
| March 19, 2024 | 8.18% |
| March 18, 2024 | 8.18% |
| March 15, 2024 | 12.34% |
| March 14, 2024 | 13.50% |
| March 13, 2024 | 13.50% |
| March 12, 2024 | 14.48% |
| March 11, 2024 | 14.48% |
| March 08, 2024 | 13.39% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-36.19%
Minimum
Sep 26 2022
106.0%
Maximum
Aug 17 2020
10.66%
Average
1.53%
Median
Oct 08 2019
1 Year Total Returns (Daily) Benchmarks
| DBV Technologies SA | -70.08% |
| Cellectis SA | 66.11% |
| PHAXIAM Therapeutics SA (DELISTED) | -- |
| Genfit SA | -11.59% |
| Innate Pharma SA | -10.27% |